- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x CA: CALCIUM ION(Non-covalent)
CA.3: 5 residues within 4Å:- Chain A: D.96
- Chain B: T.56, F.58, D.60, S.62
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Metal complexes: B:T.56, B:F.58, B:S.62, A:D.96, A:D.96
CA.16: 5 residues within 4Å:- Chain C: D.96
- Chain D: T.56, F.58, D.60, S.62
5 PLIP interactions:2 interactions with chain C, 3 interactions with chain D- Metal complexes: C:D.96, C:D.96, D:T.56, D:F.58, D:S.62
- 8 x BR: BROMIDE ION(Non-covalent)
BR.4: 5 residues within 4Å:- Chain A: R.31, W.32
- Chain B: N.214, V.215, W.324
Ligand excluded by PLIPBR.5: 5 residues within 4Å:- Chain B: N.236, R.270, I.431, T.432, T.433
Ligand excluded by PLIPBR.6: 5 residues within 4Å:- Chain A: Q.91, H.95
- Chain B: R.127, E.130
- Ligands: HEM.9
Ligand excluded by PLIPBR.7: 4 residues within 4Å:- Chain B: N.88, Q.89, P.100, F.101
Ligand excluded by PLIPBR.17: 5 residues within 4Å:- Chain C: R.31, W.32
- Chain D: N.214, V.215, W.324
Ligand excluded by PLIPBR.18: 5 residues within 4Å:- Chain D: N.236, R.270, I.431, T.432, T.433
Ligand excluded by PLIPBR.19: 5 residues within 4Å:- Chain C: Q.91, H.95
- Chain D: R.127, E.130
- Ligands: HEM.22
Ligand excluded by PLIPBR.20: 4 residues within 4Å:- Chain D: N.88, Q.89, P.100, F.101
Ligand excluded by PLIP- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.8: 3 residues within 4Å:- Chain A: T.73
- Chain B: D.288, R.293
11 PLIP interactions:7 interactions with chain B, 4 interactions with chain A- Water bridges: B:D.288, B:D.288, B:R.293, B:R.293, B:R.293, B:R.293, A:T.73, A:T.73
- Salt bridges: B:R.293
- Hydrogen bonds: A:T.73, A:T.73
SO4.12: 1 residues within 4Å:- Chain B: R.117
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.117
SO4.21: 3 residues within 4Å:- Chain C: T.73
- Chain D: D.288, R.293
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain D- Hydrogen bonds: C:T.73
- Water bridges: C:T.73, C:T.73, D:D.288, D:D.288, D:E.289
- Salt bridges: D:R.293
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
HEM.9: 22 residues within 4Å:- Chain A: M.87, G.90, Q.91, D.94, D.98, F.99, T.100
- Chain B: R.127, E.130, M.131, T.217, F.220, R.221, G.223, H.224, I.227, F.253, F.295, L.305, L.308, R.312
- Ligands: BR.6
23 PLIP interactions:4 interactions with chain A, 18 interactions with chain B, 1 Ligand-Water interactions,- Hydrophobic interactions: A:Q.91, B:E.130, B:M.131, B:F.220, B:R.221, B:I.227, B:F.253, B:F.295, B:L.305, B:L.305
- Hydrogen bonds: A:D.98, A:T.100, A:T.100
- Water bridges: B:R.221, B:R.221, B:R.221, B:R.221, B:R.221
- Salt bridges: B:R.127, B:R.221, B:R.312
- Metal complexes: B:H.224, H2O.2
HEM.22: 23 residues within 4Å:- Chain C: M.87, G.90, Q.91, D.94, D.98, F.99, T.100
- Chain D: R.127, E.130, M.131, T.217, F.220, R.221, G.223, H.224, I.227, F.253, L.294, F.295, L.305, L.308, R.312
- Ligands: BR.19
20 PLIP interactions:4 interactions with chain C, 15 interactions with chain D, 1 Ligand-Water interactions,- Hydrophobic interactions: C:Q.91, C:Q.91, D:E.130, D:M.131, D:F.220, D:R.221, D:I.227, D:F.253, D:L.294, D:F.295, D:L.305
- Hydrogen bonds: C:D.98, C:T.100
- Water bridges: D:R.221, D:R.221
- Salt bridges: D:R.127, D:R.221, D:R.312
- Metal complexes: D:H.224, H2O.19
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.10: 6 residues within 4Å:- Chain B: N.77, N.80, L.84, A.86, V.87, Q.89
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:N.80, B:V.87, B:Q.89, B:Q.89
- Water bridges: B:N.77, B:N.77, B:S.79
NAG.11: 5 residues within 4Å:- Chain B: N.113, S.115, A.116, W.257, L.261
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.113
NAG.23: 5 residues within 4Å:- Chain D: N.77, N.80, A.86, V.87, Q.89
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:A.86
- Hydrogen bonds: D:N.80, D:V.87, D:Q.89, D:Q.89
- Water bridges: D:N.77
NAG.24: 5 residues within 4Å:- Chain D: N.113, S.115, A.116, W.257, L.261
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.113
- Water bridges: D:R.258
- 6 x ACT: ACETATE ION(Non-functional Binders)
ACT.13: 4 residues within 4Å:- Chain B: P.11, P.12, R.36, R.49
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:P.11
- Water bridges: B:R.36, B:S.37, B:R.49
- Salt bridges: B:R.36, B:R.49
ACT.14: 2 residues within 4Å:- Chain B: M.410, R.413
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:M.410
- Salt bridges: B:R.413
ACT.15: 4 residues within 4Å:- Chain B: P.191, R.195, R.375, K.376
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:P.191
- Salt bridges: B:R.375, B:K.376
ACT.25: 3 residues within 4Å:- Chain D: P.12, R.36, R.49
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:P.12
- Water bridges: D:R.36, D:R.49
- Salt bridges: D:R.36, D:R.49
ACT.26: 2 residues within 4Å:- Chain D: M.410, R.413
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:R.413
ACT.27: 4 residues within 4Å:- Chain D: P.191, R.195, R.375, K.376
3 PLIP interactions:3 interactions with chain D- Salt bridges: D:R.195, D:R.375, D:K.376
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fiedler, T.J. et al., X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J.Biol.Chem. (2000)
- Release Date
- 2000-04-24
- Peptides
- MYELOPEROXIDASE: AC
MYELOPEROXIDASE: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x CA: CALCIUM ION(Non-covalent)
- 8 x BR: BROMIDE ION(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fiedler, T.J. et al., X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 A resolution. J.Biol.Chem. (2000)
- Release Date
- 2000-04-24
- Peptides
- MYELOPEROXIDASE: AC
MYELOPEROXIDASE: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BB
CD
D